Vir Biotechnology【VIR】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

9.79

買値

9.57

売値

10.08

出来高

862,834

9.58 日の範囲 10.01

6.56 52 週間の範囲 14.43

時価総額

1.348B

前日終値

9.58

始値

9.58

時刻

100

9.79

(formt)

最終取引時間

財務取引量

US$ 8,391,427

VWAP

9.7254

平均取引量 (3 か月)

2,193,767

発行済株式数

137,720,120

配当利回り

PER

-2.16

1 株当たり利益 (EPS)

-4.47

歳入

86.18M

純利益

-615.06M

Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, an... Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.vir.bio

本社

Wilmington, Delaware, USA

設立

Vir Biotechnology Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker VIR. The last closing price for Vir Biotechnology was US$9.58. Over the last year, Vir Biotechnology shares have traded in a share price range of US$ 6.56 to US$ 14.43.

Vir Biotechnology currently has 137,720,120 shares in issue. The market capitalisation of Vir Biotechnology is US$1.32 billion. Vir Biotechnology has a price to earnings ratio (PE ratio) of -2.16.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that the Company will provide a corporate update and report financial results for the...

Form 8-K - Current report

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC

– Compelling early clinical response signals for VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors ○ VIR-5818: In...

Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Vir Biotechnology Inc. (NASDAQ: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the...

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

– Designations aim to expedite the development and review of promising therapies for serious conditions with unmet medical needs – – Phase 3...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.43	-4.20743639922	10.22	10.65	8.84	1278701	9.3611402	CS
4	-0.37	-3.64173228346	10.16	11.26	8.84	1331122	10.07292227	CS
12	2.79	39.8571428571	7	14.43	6.93	2193767	10.2779267	CS
26	1.26	14.7713950762	8.53	14.43	6.56	1494092	9.48848109	CS
52	0.69	7.58241758242	9.1	14.43	6.56	1281959	9.66675323	CS
156	-22.29	-69.4825436409	32.08	33.11	6.56	1204274	16.25377712	CS
260	-7.32	-42.7819988311	17.11	141.01	6.56	1221148	27.21815618	CS

VIR - Frequently Asked Questions (FAQ)

What is the current Vir Biotechnology share price?

The current share price of Vir Biotechnology is US$ 9.79

How many Vir Biotechnology shares are in issue?

Vir Biotechnology has 137,720,120 shares in issue

What is the market cap of Vir Biotechnology?

The market capitalisation of Vir Biotechnology is USD 1.32B

What is the 1 year trading range for Vir Biotechnology share price?

Vir Biotechnology has traded in the range of US$ 6.56 to US$ 14.43 during the past year

What is the PE ratio of Vir Biotechnology?

The price to earnings ratio of Vir Biotechnology is -2.16

What is the cash to sales ratio of Vir Biotechnology?

The cash to sales ratio of Vir Biotechnology is 15.44

What is the reporting currency for Vir Biotechnology?

Vir Biotechnology reports financial results in USD

What is the latest annual turnover for Vir Biotechnology?

The latest annual turnover of Vir Biotechnology is USD 86.18M

What is the latest annual profit for Vir Biotechnology?

The latest annual profit of Vir Biotechnology is USD -615.06M

What is the registered address of Vir Biotechnology?

The registered address for Vir Biotechnology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Vir Biotechnology website address?

The website address for Vir Biotechnology is www.vir.bio

Which industry sector does Vir Biotechnology operate in?

Vir Biotechnology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M